financetom
Business
financetom
/
Business
/
Update: US Virgin Islands Port Authority Selects Aecon Consortium to Redevelop Cyril E. King Airport, Henry E. Rohlsen Airport in US Virgin Islands; National Bank Reviews Announcement
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Update: US Virgin Islands Port Authority Selects Aecon Consortium to Redevelop Cyril E. King Airport, Henry E. Rohlsen Airport in US Virgin Islands; National Bank Reviews Announcement
Mar 27, 2024 7:42 AM

10:29 AM EDT, 03/27/2024 (MT Newswires) -- Aecon Group Inc. ( AEGXF ) , which rose 2.5% and nearer to 52-week high levels, overnight Tuesday said the US Virgin Islands Port Authority has selected VIports Partners, an Aecon ( AEGXF )-led consortium, to redevelop the Cyril E. King Airport in St. Thomas and the Henry E. Rohlsen Airport in St. Croix.

The consortium will redevelop the airports under a collaborative Design, Build, Finance, Operate, and Maintain Public-Private Partnership model.

VIports is comprised of Aecon ( AEGXF ), Tikehau Star Infra, Consigli Benton Joint Venture and Avports.

Aecon Concessions will hold a 50% equity interest in the 40-year concession with Tikehau Star Infra also holding 50% of the equity. Aecon ( AEGXF ), as Design-Build lead, will also have a 50% interest in the Design-Build joint venture together with local partner J. Benton Construction.

Also, Avports will serve as the operations and maintenance partner.

Under a transition phase agreement, VIports and US Virgin Islands Port Authority will negotiate and finalize various elements of the project over nine months.

Upon completion of the transition phase, financial close is expected in the first quarter of 2025, the company said.

Meanwhile, National Bank on Wednesday reviewed Aecon Group's ( AEGXF ) announcement of the selection of Aecon ( AEGXF ) consortium by the US Virgin Islands Port Authority to redevelop the Cyril E. King and Henry E. Rohlsen airport.

"We would expect the overall return profile of the project to be similar to ARE's Bermuda ops if similar assumptions hold true, though it is worth noting that combined traffic levels for the two airports are likely +50% to +100% higher than for Bermuda's L.F. Wade International Airport," the analysts said.

National Bank has a sector perform rating with a price target of C$15.

The company's shares edged up 0.8% on last look on Wednesday.

Price: 16.81, Change: +0.14, Percent Change: +0.84

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Market Chatter: Chevron Increases Venezuelan Oil Exports Amid Improving US Relations
Market Chatter: Chevron Increases Venezuelan Oil Exports Amid Improving US Relations
Feb 14, 2025
03:52 PM EST, 02/14/2025 (MT Newswires) -- Chevron ( CVX ) plans to increase its Venezuelan oil exports this month, aiming to boost shipments of synthetic crude from the Petropiar project to a seven-year high, Bloomberg reported Friday, citing sources with knowledge of the matter. Petropiar output is projected to rise about 50% to around 143,000 barrels a day following...
-- Primaris REIT Brief: Keeps Sector Perform, Target Edges Up To C$17.25 From $17 On
-- Primaris REIT Brief: Keeps Sector Perform, Target Edges Up To C$17.25 From $17 On "Strong" Q4 Results and Outlook, But Says "Macro Volatility Looms in the Background"
Feb 14, 2025
03:35 PM EST, 02/14/2025 (MT Newswires) -- Price: 15.35, Change: +0.64, Percent Change: +4.35 ...
Corbus Pharmaceuticals Reports Positive Data From Cancer Drug Trial -- Shares Slump
Corbus Pharmaceuticals Reports Positive Data From Cancer Drug Trial -- Shares Slump
Feb 14, 2025
03:32 PM EST, 02/14/2025 (MT Newswires) -- Corbus Pharmaceuticals ( CRBP ) shares slumped 10% in recent trading Friday despite reporting what it described as encouraging data from the Western clinical trial of its CRB-701 anti-body drug conjugate. A total of 26 patients with metastatic urothelial cancer and other solid tumors associated with Nectin-4 expression were evaluable at December 2024...
Moderna Norovirus Vaccine Trial Placed on Hold by FDA After Adverse Event
Moderna Norovirus Vaccine Trial Placed on Hold by FDA After Adverse Event
Feb 14, 2025
03:45 PM EST, 02/14/2025 (MT Newswires) -- Moderna ( MRNA ) said Friday its trial for a trivalent vaccine against norovirus is currently on hold by the US Food and Drug Administration after a single adverse event report of a close of Guillain-Barre syndrome. Investigation of the adverse event is currently underway, according to the company. Moderna ( MRNA )...
Copyright 2023-2026 - www.financetom.com All Rights Reserved